Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0G3GR
|
|||
| Former ID |
DIB004948
|
|||
| Drug Name |
E7/HSP70 DNA vaccine
|
|||
| Synonyms |
E7/HSP70 DNA vaccine, Johns Hopkins University; E7/VP22 DNA vaccine, Johns Hopkins University; HPV-DNA fusion protein vaccine (anticancer), Johns Hopkins University; PNGVL4a-Sig/E7(detox)/HSP70 DNA vaccine, Johns Hokins University
Click to Show/Hide
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42] | Phase 2 | [1], [2] | |
| Company |
Johns Hopkins University
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis. Curr Obstet Gynecol Rep. 2014 Mar 1;3(1):18-32. | |||
| REF 2 | Assessing Therapeutic Effects of Vaccination. Johns Hopkins University report. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.